About
Cancer Gene Therapy
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyJapan
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
40
By Phase
PHASE2: 1PHASE1/PHASE2: 1PHASE1: 1
By Status
UNKNOWN: 1COMPLETED: 1WITHDRAWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT04013334Lead Sponsor
MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma
PHASE2Unknown
12 participants
Started: Aug 15, 2019 · Completed: Jan 1, 2023
NCT01931046Lead Sponsor
Use of Recombinant Adenovirus Therapy to Treat Localized Prostate Cancer
PHASE1/PHASE2Completed
28 participants
Started: Oct 31, 2013 · Completed: Mar 31, 2020
NCT01197209Lead Sponsor
Neoadjuvant Study of In-situ REIC/Dkk-3 in Prostate Cancer
PHASE1Withdrawn
Started: Sep 30, 2010 · Completed: Dec 31, 2010
Locations (1)
Headquarters
Okayama, Japan
Map
Loading map...